Ww announces study results showing clinically significant improvements for people living with diabetes on customized program

Positive clinical trial results revealed at ada 82nd scientific sessions new york , june 4, 2022 /prnewswire/ -- ww international, inc. (nasdaq: ww) ("weightwatchers," "ww," or "the company") announced today, at the american diabetes association (ada) 82nd scientific sessions, positive results from its three-center clinical trial testing the effectiveness of its program tailored for those living with diabetes on weight management, as well as overall health and well-being. it is estimated that 90 percent of people living with diabetes are also living with overweight or obesity, and 30-53 percent of new diabetes cases in the u.s. yearly are linked to obesity.
WW Ratings Summary
WW Quant Ranking